PharmAla Issues Q2 Financial Statements

Go back to PharmAla Issues Q2 Financial Statements
Medmark Group Inc New (AMEX: MDMA) Delayed: 0.00 --0 (-0%)
Previous Close $0.00    52 Week High $0.00 
Open $0.00    52 Week Low $0.00 
Day High $0.00    P/E N/A 
Day Low $0.00    EPS $0.00 
Volume 0       

(AMEX: MDXXF) Delayed: 0.14 -0.01 (6.67%)
Previous Close $0.15    52 Week High $ 
Open $0.14    52 Week Low $ 
Day High $0.14    P/E N/A 
Day Low $0.14    EPS $ 
Volume 1,000